5-chloro-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)pentanamide
95%
- Product Code: 64564
| Molecular Weight: | 391.81 g./mol | Molecular Formula: | C₁₈H₁₈ClN₃O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of targeted cancer therapies. It functions as a key component in proteolysis-targeting chimeras (PROTACs), which are designed to degrade specific disease-causing proteins. By facilitating the ubiquitination and subsequent degradation of these proteins, it plays a crucial role in inhibiting cancer cell proliferation and survival. Additionally, its structure is optimized for binding to E3 ubiquitin ligases, making it a valuable tool in the design of novel therapeutic agents for treating various malignancies. Its application extends to research in understanding protein degradation pathways and developing innovative treatments for other protein-related diseases.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Light yellow solid |
| PURITY | 94.5-100 |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $226.52 |
+
-
|
| 0.250 | 10-20 days | $453.04 |
+
-
|
| 1.000 | 10-20 days | $887.98 |
+
-
|
| 10.000 | 10-20 days | $3,469.73 |
+
-
|
5-chloro-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)pentanamide
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of targeted cancer therapies. It functions as a key component in proteolysis-targeting chimeras (PROTACs), which are designed to degrade specific disease-causing proteins. By facilitating the ubiquitination and subsequent degradation of these proteins, it plays a crucial role in inhibiting cancer cell proliferation and survival. Additionally, its structure is optimized for binding to E3 ubiquitin ligases, making it a valuable tool in the design of novel therapeutic agents for treating various malignancies. Its application extends to research in understanding protein degradation pathways and developing innovative treatments for other protein-related diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :